Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Bisordi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|August 11, 2023
Walking the talk in digital transformation of regulatory reviewRamy Khalil, Judith C Macdonald, Andrew Gustafson, et al.
Future Oncology (London, England)|August 29, 2014
Neoadjuvant breast cancer treatment as a sensitive setting for trastuzumab biosimilar development and extrapolationChristian Jackisch, Frank A Scappaticci, Dominik Heinzmann, et al.
Nature Reviews. Drug Discovery|June 5, 2020
Cloud-based data systems in drug regulation: an industry perspectiveAndrew S Robertson, Hilary Malone, Fabio Bisordi, et al.
Clinical Pharmacology and Therapeutics|April 28, 2020
Creating E-Labeling Platforms: An Industry VisionKhyati Roberts, Roopal Thakkar, Deborah Autor, et al.
Therapeutic Innovation & Regulatory Science|December 5, 2025
A Call To Action: Developing an Agile Global Regulatory Affairs Workforce for the FutureLina AlJuburi, Nicole Mahoney, Eddie Reilly, et al.
Nature Reviews. Drug Discovery|February 2, 2026
Accelerating the drug regulatory process through a federated cloud ecosystemAndrew S Robertson, Nahid Latif, Raymond C Votzmeyer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|August 11, 2023
Walking the talk in digital transformation of regulatory reviewRamy Khalil, Judith C Macdonald, Andrew Gustafson, et al.
Future Oncology (London, England)|August 29, 2014
Neoadjuvant breast cancer treatment as a sensitive setting for trastuzumab biosimilar development and extrapolationChristian Jackisch, Frank A Scappaticci, Dominik Heinzmann, et al.
Nature Reviews. Drug Discovery|June 5, 2020
Cloud-based data systems in drug regulation: an industry perspectiveAndrew S Robertson, Hilary Malone, Fabio Bisordi, et al.
Clinical Pharmacology and Therapeutics|April 28, 2020
Creating E-Labeling Platforms: An Industry VisionKhyati Roberts, Roopal Thakkar, Deborah Autor, et al.
Therapeutic Innovation & Regulatory Science|December 5, 2025
A Call To Action: Developing an Agile Global Regulatory Affairs Workforce for the FutureLina AlJuburi, Nicole Mahoney, Eddie Reilly, et al.
Nature Reviews. Drug Discovery|February 2, 2026
Accelerating the drug regulatory process through a federated cloud ecosystemAndrew S Robertson, Nahid Latif, Raymond C Votzmeyer, et al.
Pageof 1